Telomere Length Has Prognostic Impact in B-Cell Chronic Lymphocytic Leukemia (B-CLL).
Irene Ricca(University of Turin), Marco Ladetto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mario Boccadoro(University of Turin), Maria Elena Dell’Aquila(University of Bari Aldo Moro), Alberto Rocci(University of Turin), Carlo Marinone(Azienda Sanitaria Locale Alessandria), L Bergui(University of Turin), Daniela Drandi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Corrado Tarella(European Institute of Oncology), Barbara Mantoan(University of Turin), Claudia Castellino(Carle Foundation Hospital), Mara Compagno(Boston Children's Hospital), Daniele Caracciolo(Magna Graecia University), Roberto Francese(University of Turin), Sonia Vallet(Universitätsklinikum Krems), Loredana Santo(Division of Cancer Epidemiology and Genetics), Francesca Ficara(Humanitas University), Mario Bazzan(Ospedale San Giovanni Bosco), Andrea Gallamini(Centre Antoine Lacassagne)
Cited by 0
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|920